Copyright
©2007 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 21, 2007; 13(39): 5238-5244
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5238
Published online Oct 21, 2007. doi: 10.3748/wjg.v13.i39.5238
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up
Renato Caviglia, Mentore Ribolsi, Marina Rizzi, Sara Emerenziani, Maria Laura Annunziata, Michele Cicala, Department of Digestive Diseases, Campus Bio-Medico University, Rome, Italy
Author contributions: All authors contributed equally to the work.
Correspondence to: Renato Caviglia, MD, PhD, University Campus Bio-Medico, Department of Digestive Disease, Via E. Longoni, Rome 8300155, Italy. r.caviglia@unicampus.it
Telephone: +39-62-2541560 Fax: +39-62-2541520
Received: May 15, 2007
Revised: August 8, 2007
Accepted: September 24, 2007
Published online: October 21, 2007
Revised: August 8, 2007
Accepted: September 24, 2007
Published online: October 21, 2007
Core Tip